PMID- 16878852
OWN - NLM
STAT- MEDLINE
DCOM- 20060824
LR  - 20191110
IS  - 1533-1458 (Print)
IS  - 1533-1458 (Linking)
VI  - 29
IP  - 3 Suppl
DP  - 2006 May-Jun
TI  - Intravenous immunoglobulin use for neurologic diseases.
PG  - S21-8
AB  - Intravenous immunoglobulin (IVIG) has been used primarily for immune deficiency 
      patients, and its greatest expansion is seen more and more in the treatment of 
      autoimmune disorders, especially in neurology. The benefits of IVIG treatment 
      include its availability in all treatment centers and its ease of administration 
      in an outpatient setting. This article gives an overview of some autoimmune 
      neurologic diseases and explores the clinical evidence supporting the use of 
      IVIG.
FAU - Koski, Carol Lee
AU  - Koski CL
AD  - University of Maryland School of Medicine, Baltimore, USA.
FAU - Patterson, Jardiolyn Valino
AU  - Patterson JV
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - J Infus Nurs
JT  - Journal of infusion nursing : the official publication of the Infusion Nurses 
      Society
JID - 101124170
RN  - 0 (Immunoglobulins, Intravenous)
RN  - 0 (Immunologic Factors)
MH  - Acute Disease
MH  - Ambulatory Care
MH  - Autoimmune Diseases of the Nervous System/*drug therapy/immunology
MH  - Chronic Disease
MH  - Dermatomyositis/drug therapy
MH  - Evidence-Based Medicine
MH  - Guillain-Barre Syndrome/drug therapy
MH  - Humans
MH  - Immunoglobulins, Intravenous/adverse effects/immunology/*therapeutic use
MH  - Immunologic Factors/adverse effects/immunology/*therapeutic use
MH  - Lambert-Eaton Myasthenic Syndrome/drug therapy
MH  - Myasthenia Gravis/drug therapy
MH  - *Patient Selection
MH  - Plasma Exchange
MH  - Polymyositis/drug therapy
MH  - Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/drug therapy
MH  - Treatment Outcome
RF  - 34
EDAT- 2006/08/02 09:00
MHDA- 2006/08/25 09:00
CRDT- 2006/08/02 09:00
PHST- 2006/08/02 09:00 [pubmed]
PHST- 2006/08/25 09:00 [medline]
PHST- 2006/08/02 09:00 [entrez]
AID - 10.1097/00129804-200605001-00003 [doi]
PST - ppublish
SO  - J Infus Nurs. 2006 May-Jun;29(3 Suppl):S21-8. doi: 
      10.1097/00129804-200605001-00003.